Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 30, 2006

CytoGenix’ Gene Silencing ssDNA Technology Patent Allowed in Europe and India

  • CytoGenix received notices of allowances for grant of patent applications covering the technology for expressing ssDNA in vivo from the Indian and European Community Patent Offices. These notices follow the previous notice of allowance for these applications from the Peoples Republic of China.

    Filed in 1999 and 2000, these patents cover the company's single-strand DNA expression system covered by a U.S. patent. It is used in the company's Simplivir™ antiherpes and CY303 anti-inflammation products.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »